<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2025-06-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment." The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of early Lyme disease as manifested by erythema migrans (EM). This guidance finalizes the draft guidance of the same name issued on February 1, 2023.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-11809</p>
    <p><strong>Publication Date:</strong> 2025-06-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/06/26/2025-11809/early-lyme-disease-as-manifested-by-erythema-migrans-developing-drugs-for-treatment-guidance-for">https://www.federalregister.gov/documents/2025/06/26/2025-11809/early-lyme-disease-as-manifested-by-erythema-migrans-developing-drugs-for-treatment-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-11809</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
